PharmAust (ASX:PAA) is gearing up to begin a pivotal Phase 2 study in Australia with its lead veterinary drug candidate, monepantel, for the treatment of lymphoma in canines, which if successful, could open the door to...
Tag - PAA
Reporting on the healthcare industry’s corporate and clinical developments, executive moves and views from the Street.
Copyright © 2019 BioTuesday Publishing Corporation - Privacy Policy